“The FDA said injecting anything directly into a person’s bloodstream can ‘lead to serious and life-threatening conditions.’”
We truly try to steer clear of clickbait and aggregated content at Talking Joints Memo, but let’s be real here—we’re just like everybody else, and when we saw the words “injectable cannabis” hitting headlines this past weekend, we started feverishly clicking.
The scoop comes courtesy of Lester Black, whose SF Gate reporting on all things weed-related is always top notch. In this case, he broke the story last week that the “Food and Drug Administration warned a California cannabis company that its injectable hemp CBD could be posing ‘serious harm’ to public health, telling the company that its product is violating federal law.” Here’s more:
Pico IV sells a purified version of CBD, a non-intoxicating compound produced by cannabis, that is designed to be injected into the bloodstream through an intravenous infusion. The Sacramento company has testimonials on its website that say the CBD IV therapy can help treat chronic pain, Crohn’s disease and arthritis.
The FDA, however, warned Pico IV in a Monday letter that it is breaking the law by marketing CBD as a “dietary supplement,” even though it is explicitly designed to not be ingested and instead be injected. The agency also said the product is “especially concerning” because injectable drugs “can pose risks of serious harm to users.” The FDA said injecting anything directly into a person’s bloodstream can “lead to serious and life-threatening conditions.”
It’s not our style to agree with the FDA on weed issues, but in this case, we’re in alignment. We still plan on attempting to crush up and sniff some THCA diamonds in the near future, but the only syringe that we want to see near a dispensary is one that’s filled with RSO to squirt in our coffee.
